ClydeEMarkowitzMD
Neurology • Philadelphia, PANeuroimmunology/Multiple Sclerosis
Associate Professor of Neurology, University Pennsylvania
Dr. Markowitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3400 Spruce Street
2 Ravdin Building
Philadelphia, PA 19104Phone+1 215-662-3606- Is this information wrong?
Education & Training
New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 1991 - 1994- New York Presbyterian Hospital (Columbia Campus)Internship, Internal Medicine, 1990 - 1991
Columbia University Vagelos College of Physicians and SurgeonsClass of 1990
Certifications & Licensure
PA State Medical License 1998 - 2024
NY State Medical License 1992 - 2001- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis Start of enrollment: 2005 Apr 01
- Efficacy and Safety of MBP8298 in Subjects With Secondary Progressive Multiple Sclerosis Start of enrollment: 2007 Jun 01
- Vitamin D Supplementation in Multiple Sclerosis Start of enrollment: 2012 Mar 01
Publications & Presentations
PubMed
- 1 citationsSphingosine 1-phosphate receptor modulators in multiple sclerosis treatment: A practical review.Freedman, M., Coyle, P., Cohen, B., Cree, B., Markowitz, C.> ;Annals of Clinical and Translational Neurology. 2024 Feb 16
- A Proposed Approach to Screening and Surveillance Labs for Patients With Multiple Sclerosis on Anti-CD20 Therapy.Lenzi, K., Gandelman, S., Markowitz, C., Berger, J.> ;Neurology. Clinical Practice. 2024 Feb 1
- Mapping the Relationship of White Matter Lesions to Depression in Multiple Sclerosis.Baller, E., Sweeney, E., Cieslak, M., Robert-Fitzgerald, T., Covitz, S., Martin, M., Schindler, M., Bar-Or, A., Elahi, A., Larsen, B., Manning, A., Markowitz, C., Perr...> ;Biological Psychiatry. 2023 Nov 18
- Join now to see all
Press Mentions
New Drug, TASCENSO ODT® (Fingolimod), Launched to Meet the Needs of Multiple Sclerosis Patients in the US Left Without Essential Patient SupportFebruary 13th, 2023- Four People in the World Have a Mysterious Dementia. Could It Hold a Key to Alzheimer's?July 11th, 2021
New MS Drug Approved by FDAMarch 29th, 2017
Hospital Affiliations
Hospital of the University of PennsylvaniaPhiladelphia, Pennsylvania- Penn Presbyterian Medical CenterPhiladelphia, Pennsylvania
Pennsylvania HospitalPhiladelphia, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
